Hikma Pharmaceuticals Eyes Aggressive Regional Expansion

Hikma Pharmaceuticals, the London and Nasdaq Dubai-listed pharmaceutical group with a strong presence in the Middle East and North Africa region, plans to expand in the region through more acquisitions this year.
Zawya